Showing results (11-20 of 117) with videos related to
Sort By:
Pageof 12
Drugs|June 15, 2011
Pharmacotherapeutic management of locally advanced prostate cancer: current statusJarad M Martin, Stephane Supiot, Dominik R BertholdJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2005
Management of advanced prostate cancer after first-line chemotherapyDominik R Berthold, Cora N Sternberg, Ian F TannockNature Reviews. Clinical Oncology|January 27, 2010
Advanced pancreatic carcinoma: current treatment and future challengesAnastasios Stathis, Malcolm J MooreFuture Oncology (London, England)|June 6, 2007
Erlotinib: success of a molecularly targeted agent for the treatment of advanced pancreatic cancerStephen A Welch, Malcolm J MooreFrontiers in Immunology|May 23, 2022
Overcoming Immune Resistance With Radiation Therapy in Prostate CancerArthur Mulvey, Emilien Muggeo-Bertin, Dominik R Berthold, et al.European Urology|December 31, 2010
Non-risk-adapted surveillance in clinical stage I nonseminomatous germ cell tumors: the Princess Margaret Hospital's experienceJeremy F Sturgeon, Malcolm J Moore, David M Kakiashvili, et al.American Journal of Clinical Pathology|June 1, 2005
Epidermal growth factor receptor expression in anal canal carcinomaLyly H Lê, Runjan Chetty, Malcolm J MooreRevue Medicale Suisse|May 18, 2026
[Intensification of radio-hormone therapy for prostate cancer]Basile Saffiedine, Petros Tsantoulis, Natacha Bourry, et al.The Lancet. Oncology|December 11, 2002
The role of systemic chemotherapy in the management of muscle-invasive bladder cancerHelen G Juffs, Malcolm J Moore, Ian F TannockExpert Opinion on Pharmacotherapy|January 26, 2006
A review of erlotinib and its clinical usePatricia A Tang, Ming-Sound Tsao, Malcolm J MoorePageof 12